| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | -0.49 | 0.1 |
| mRNA | serdemetan | FIMM | pan-cancer | AAC | -0.35 | 0.02 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.28 | 3e-06 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | -0.25 | 6e-05 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | -0.23 | 3e-05 |
| mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | -0.23 | 0.4 |
| mRNA | Cyclopamine | FIMM | pan-cancer | AAC | -0.21 | 0.2 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.21 | 1e-08 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | -0.2 | 0.002 |
| mRNA | selumetinib:PLX-4032 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.2 | 1e-06 |